Search

Zai Lab Ltd ADR

Aperta

SettoreSettore sanitario

24.84 2.48

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

24.15

Massimo

24.98

Metriche Chiave

By Trading Economics

Entrata

191K

-51M

Vendite

6.7M

106M

EPS

-0.46

Margine di Profitto

-47.808

Dipendenti

1,784

EBITDA

-2.1M

-46M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+60.02% upside

Dividendi

By Acuity

Utili prossimi

5 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

892M

2.9B

Apertura precedente

22.36

Chiusura precedente

24.84

Notizie sul Sentiment di mercato

By Acuity

38%

62%

77 / 339 Classifica in Healthcare

Zai Lab Ltd ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 set 2026, 23:51 UTC

News

Rimini Street shares lower in after-market trading despite announcing a partnership with Datacom to support Oracle and SAP software in Australia and New Zealand.

14 set 2026, 23:51 UTC

News

Shares of Gartner Inc are lower in after-market hours following unusual weakness, despite the recent launch of its IT Symposium/Xpo conference highlighting key technology trends.

14 set 2026, 23:41 UTC

News

Autodesk shares are lower in after-market hours following a Neutral rating from Cantor Fitzgerald, which set a price target of $215.00.

14 set 2026, 23:36 UTC

Correlated Moves
News

ATI Inc will highlight aerospace opportunities at the Morgan Stanley Laguna Conference on September 17, 2026. Shares were higher in after-market trading.

14 set 2026, 23:36 UTC

News

NextEra Energy plans to enhance its merger proposal with Dominion Energy by extending bill credits and creating 600 new jobs in Virginia. Shares rose in after-market hours.

14 set 2026, 23:31 UTC

News

Northrop Grumman Corp received a $34,388,301 contract modification for military helicopter components. Shares declined in after-market trading despite the news.

14 set 2026, 23:31 UTC

News
Social Media

Lockheed Martin secured over $1.3 billion in defense contracts from the U.S. Department of War, with shares trading higher in after-market hours.

14 set 2026, 23:31 UTC

News
Social Media

Scholar Rock Holding Corp shares declined in after-market trading following FDA approval of Isembyld, amid concerns over pricing and treatment risks.

14 set 2026, 23:26 UTC

Correlated Moves
News

NXP Semiconductors NV gains in after-market trading, supported by its focus on physical AI and a shift to asset-light manufacturing for automotive revenue.

14 set 2026, 23:21 UTC

Event
News

Children's Place reported second-quarter net sales of $241.8 million, missing estimates, and shares fell sharply in after-hours trading following the results.

14 set 2026, 23:21 UTC

Correlated Moves
News

The U.S. dollar strengthens against major currencies, boosting USD/DKK amid expectations of a Fed interest rate hike following higher inflation figures.

14 set 2026, 23:16 UTC

News

Walt Disney Co is requiring more remote employees to return to the office four days a week. Shares are little changed in after-market trading.

14 set 2026, 23:11 UTC

News

Leonardo DRS rises in after-market on Guggenheim Buy rating.

14 set 2026, 23:11 UTC

Correlated Moves
News

The U.S. dollar strengthens against major currencies, including USD/CZK, amid expectations of a Federal Reserve interest rate hike following rising inflation.

14 set 2026, 23:06 UTC

Correlated Moves
News

Morgan Stanley's shares are advancing in after-market trading, influenced by Goldman Sachs' performance amid rising crude oil prices and supply concerns.

14 set 2026, 23:06 UTC

News

Uranium Energy Corp shares are lower in after-market hours amid rising crude oil prices and concerns over future uranium supply dynamics from Saudi Arabia's recent discoveries.

14 set 2026, 23:06 UTC

News

Marathon Petroleum shares are higher in after-market trading following recognition at the Fleet Safety Awards, reflecting positive sentiment amid global fuel supply constraints.

14 set 2026, 23:06 UTC

News
Social Media

Eli Lilly's Foundayo captures over 30% of new U.S. obesity patients, boosting shares higher in after-market hours amid strong demand for oral treatments.

14 set 2026, 23:06 UTC

News

NVIDIA shares are higher in after-hours trading following President Trump's remarks dismissing AI regulation concerns during a call with CEO Jensen Huang.

14 set 2026, 23:06 UTC

News

Target Corp appointed Mark Weinstein as Chief Marketing and Guest Experience Officer, a move aimed at enhancing consumer engagement. Shares are trading higher in after-market hours.

14 set 2026, 23:06 UTC

News

Accenture PLC shares are lower in after-market hours following a $25 million settlement over discrimination claims. Broader market pressures also weigh on the stock.

14 set 2026, 23:06 UTC

News

Ethereum is trading higher amid positive market sentiment and rising crude oil prices. The Federal Reserve's expected interest rate hike adds complexity to the market.

14 set 2026, 23:06 UTC

News

Bitcoin is trading higher amid rising crude oil prices and inflation concerns. U.S. Treasury yields reaching 5% also impact investor sentiment towards the digital asset.

14 set 2026, 23:06 UTC

News

Ethereum is trading higher amid positive sentiment, despite intraday volatility. Crude oil price surges and upcoming Fed rate hike add complexity to market dynamics.

14 set 2026, 23:06 UTC

News

Bitcoin is trading higher amid rising crude oil prices and heightened inflation concerns. U.S. Treasury yields have also reached 5%, impacting investor sentiment.

14 set 2026, 23:01 UTC

News

BlackRock shares are rising in after-market trading following CEO Larry Fink's participation in a summit aimed at attracting C$1 trillion in global investments to Canada.

14 set 2026, 23:01 UTC

News

Dave and Buster's Entertainment shares fell after the company reported a $12.5 million net loss and revenue that missed expectations during after-market hours.

14 set 2026, 23:01 UTC

News

Radiant Logistics reports fourth-quarter revenue of $261.4 million, an 18.5% increase, and net income of $7.5 million, driving shares higher in after-market trading.

14 set 2026, 23:01 UTC

News

Leidos Holdings has secured an $875 million Navy contract for network management, boosting shares in after-market hours.

14 set 2026, 23:01 UTC

Event
News

Enova International withdrew its acquisition applications for Grasshopper Bancorp, leading shares lower in after-market hours. The company reaffirmed its guidance for 2026.

Confronto tra pari

Modifica del prezzo

Zai Lab Ltd ADR Previsione

Obiettivo di Prezzo

By TipRanks

60.02% in crescita

Previsioni per 12 mesi

Media 39.333 USD  60.02%

Alto 45 USD

Basso 36 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Zai Lab Ltd ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

3 ratings

3

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

77 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat